9887.HK
LEADS BIOLABS
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
News
- Leads Biolabs enrolls the first patient in a Phase Ib/II combination trial of opamtistomig, a PD-L1/4-1BB bispecific antibody, in metastatic colorectal cancerOct 16, 2026
- Lead Biolabs' opamtistomig, a PD-L1/4-1BB bispecific antibody, receives FDA Fast Track designation for first-line advanced or metastatic biliary tract cancerOct 12, 2026